TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT07045194: Virtue® SAB in the Treatment of Coronary ISR Trial

Sponsor: Orchestra BioMed, Inc · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 740 pts

Competing Trials Overlap

14 Active Trials

Excess Burn Exposure

$7,636,000

Rescue Site Savings

+$5,046,400

Unlock Full NCT07045194 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07045194 Rescue Dossier →